Guanine Monophosphate Synthetase (GMPS) (Middle Region) Peptide
GMPS
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all GMP Synthase (GMPS) products
- GMP Synthase (GMPS) (Guanine Monophosphate Synthetase (GMPS))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-GMPS antibody (Catalog #: ARP48619_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GMP Synthase (GMPS) (Guanine Monophosphate Synthetase (GMPS))
- Synonyms
- GMPS Peptide, AA591640 Peptide, AI047208 Peptide, sb:cb632 Peptide, wu:fb76b01 Peptide, wu:fi05a09 Peptide, zgc:66002 Peptide, guanine monophosphate synthase Peptide, guanine monophosphate synthase L homeolog Peptide, guanine monophosphate synthetase Peptide, GMPS Peptide, gmps.L Peptide, gmps Peptide, Gmps Peptide
- Background
-
In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.
Alias Symbols: -
Protein Interaction Partner: SUMO4,C19orf62,TCEAL1,USP7
Protein Size: 693 - Molecular Weight
- 77 kDa
- Gene ID
- 8833
- NCBI Accession
- NM_003875, NP_003866
- UniProt
- P49915
-
You are here:
